{"id":1116,"date":"2020-06-27T23:22:54","date_gmt":"2020-06-27T21:22:54","guid":{"rendered":"http:\/\/vaccine-research-institute.fr\/?post_type=member&#038;p=1116"},"modified":"2025-12-05T14:07:44","modified_gmt":"2025-12-05T13:07:44","slug":"yves-levy","status":"publish","type":"member","link":"https:\/\/vaccine-research-institute.fr\/fr\/team\/yves-levy\/","title":{"rendered":"Yves L\u00e9vy"},"content":{"rendered":"<p><strong>Pr. Yves Le\u0301vy<\/strong> MD, PhD is Professor of clinical immunology. He was appointed <strong>CEO and Chairman of INSERM (French National Institute for Health and Medical research)<\/strong> from 2014-2018. He serves also as <strong>Chairman President of the Alliance for Health and Life Sciences (Aviesan)<\/strong> of the main stakeholders of life and health sciences in France.<\/p>\n<p>In the last 25 years, Pr. Yves Le\u0301vy\u2019s research activities have focused on field of immunology and infectious diseases, immune-based therapies and development of vaccines against HIV and also other infectious diseases. From 1996 to present he led several INSERM research teams in France and in USA.<\/p>\n<p><strong>Pr. Yves Le\u0301vy has created the Vaccine Research Institute (VRI)<\/strong>. The VRI&rsquo;s structure strengthens the links between basic, translational research, patients\u2019 associations and the socioeconomic world to develop vaccines against (re)-emerging pathogens. The VRI includes a large network of teams In France, Europe and US gathering key international opinion leaders through a unique collaborative network and with a central strategic plan.<\/p>\n<p>In his career Pr. Yves Le\u0301vy has <strong>moved up to ten candidate vaccines until clinical development<\/strong> through academic or public\/ industrial partnership. Through this expertise, Pr. Y. Le\u0301vy has been instrumental in designing and implementing early proof-of-concept and Phase 3 clinical trials in France, Europe and internationally. Y. Le\u0301vy has published more than 400 original papers.<\/p>\n<p>In his recent positions, Pr. Yves Le\u0301vy was appointed by the previous General Secretary of the United Nations as an <strong>expert member of the UN \u201cGlobal Health Crises\u201d Task Force<\/strong> in 2016 till 2018 and <strong>\u201cSpecial Envoy\u201d of the French Government for the coordination of the fight against Ebola in Central Africa<\/strong> in 2019. He is co founder and Chief Scientific and Medical Officer of the biotech EnnoDC (LinKinVax), a spin-off of the VRI created in 2020 to develop vaccine against infectious diseases and cancer.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pr. Yves Le\u0301vy MD, PhD is Professor of clinical immunology. He was appointed CEO and Chairman of INSERM (French National Institute for Health and Medical research) from 2014-2018. He serves also as Chairman President of the Alliance for Health and Life Sciences (Aviesan) of the main stakeholders of life and health sciences in France. In [&hellip;]<\/p>\n","protected":false},"featured_media":172,"template":"","class_list":["post-1116","member","type-member","status-publish","has-post-thumbnail","hentry","wpautop"],"_links":{"self":[{"href":"https:\/\/vaccine-research-institute.fr\/fr\/wp-json\/wp\/v2\/member\/1116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vaccine-research-institute.fr\/fr\/wp-json\/wp\/v2\/member"}],"about":[{"href":"https:\/\/vaccine-research-institute.fr\/fr\/wp-json\/wp\/v2\/types\/member"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vaccine-research-institute.fr\/fr\/wp-json\/wp\/v2\/media\/172"}],"wp:attachment":[{"href":"https:\/\/vaccine-research-institute.fr\/fr\/wp-json\/wp\/v2\/media?parent=1116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}